Australasian Journal of Dermatology最新文献

{"title":"Informing a Position Statement on the Use of Large Language Models and AI Scribes in Dermatology in Australia","authors":"Liam J. Caffery,&nbsp;Monica L. Taylor,&nbsp;Lisa M. Abbott,&nbsp;Monika Janda,&nbsp;Pascale Guitera,&nbsp;Victoria Mar,&nbsp;Chris Arnold,&nbsp;Stephen Shumack,&nbsp;Tony Caccetta,&nbsp;Robert Miller,&nbsp;H. Peter Soyer","doi":"10.1111/ajd.14566","DOIUrl":"10.1111/ajd.14566","url":null,"abstract":"<p>Artificial Intelligence (AI) refers to the ability of computers to mimic human intelligence. In response to the growing interest and impact of AI, the Australasian College of Dermatologists released its first Position Statement on AI in dermatology in 2022. This Position Statement provided guidance for dermatologists on the appropriate use of AI. Since then, the AI landscape has evolved substantially, particularly with the emergence of Large Language Models (LLMs). This article explores key developments in AI driven by LLMs, including the increasing use of AI scribes, and provides updated guidance for dermatologists in Australia.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 6","pages":"e335-e341"},"PeriodicalIF":1.8,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajd.14566","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144658243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Linear Focal Elastosis: What We Know From Epidemiological Studies","authors":"Tim Aung,&nbsp;Rowland Noakes,&nbsp;Kais Kasem,&nbsp;Dedee F. Murrell","doi":"10.1111/ajd.14569","DOIUrl":"10.1111/ajd.14569","url":null,"abstract":"<p>Linear focal elastosis (LFE), characterised by horizontal streaks on the lower back, is a dermatological condition with unclear etiopathogenesis and limited epidemiological data. This study synthesises case reports to elucidate demographic patterns, clinical manifestations, and potential associations. A literature search across PubMed, Embase, Ovid and ResearchGate identified 37 relevant articles, yielding 80 cases after excluding duplicates and irrelevant articles. In analysis, the male-to-female ratio for LFE was 5:1, with a mean age of 39 years. Cases were more common among adolescents and older adults (age ≥ 60), with the majority occurring in pubertal adolescents. No racial predilection was observed. The lower back was the most frequently affected site, with rare cases involving other body parts. Some cases were associated with growth spurts or strenuous exercise, although the etiopathogenesis remains speculative. LFE may be underreported due to its asymptomatic nature and resemblance to other skin conditions, particularly striae distensae. Further research is required to clarify its pathogenesis and explore potential treatment options.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 6","pages":"364-368"},"PeriodicalIF":1.8,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajd.14569","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144940349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recalcitrant Erythema Multiforme Minor Successfully Treated With Apremilast—A Novel Insight","authors":"Carmen Cánovas Seva,&nbsp;Lorena Martínez Leboráns,&nbsp;Carlos Aliste Santos,&nbsp;Jose Manuel Suárez Peñaranda,&nbsp;Ángeles Flórez","doi":"10.1111/ajd.14564","DOIUrl":"10.1111/ajd.14564","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 6","pages":"e371-e373"},"PeriodicalIF":1.8,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144641632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response to Letter by Wallace et al.","authors":"Samantha Ting,&nbsp;Patricia Lowe,&nbsp;Pablo Fernández-Peñas","doi":"10.1111/ajd.14568","DOIUrl":"10.1111/ajd.14568","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 6","pages":"e384-e385"},"PeriodicalIF":1.8,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144641633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Successful Treatment of Spontaneous Generalised Keloids With Dupilumab: A Case Report.","authors":"Lachlan D W Lau, Nicholas Manuelpillai, Holly Sexton, Laura Scardamaglia","doi":"10.1111/ajd.14572","DOIUrl":"https://doi.org/10.1111/ajd.14572","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144641634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Guselkumab for Psoriasis in Patients With Active or Prior Malignancy: A Multicentre Retrospective Study","authors":"Francisco Javier Melgosa Ramos,&nbsp;Sergio Santos Alarcón,&nbsp;Almudena Mateu Puchades,&nbsp;Isabel Belinchón Romero,&nbsp;Gemma Mª. Pérez Pastor,&nbsp;Luca Schneller-Pavelescu Apetrei,&nbsp;Francisco Javier Mataix Díaz,&nbsp;Antonio Martorell,&nbsp;Manel Velasco Pastor,&nbsp;José María Ortíz Salvador,&nbsp;Antonio Sahuquillo Torralba,&nbsp;Marta Galarreta Pascual,&nbsp;Jorge Magdaleno Tapial","doi":"10.1111/ajd.14573","DOIUrl":"https://doi.org/10.1111/ajd.14573","url":null,"abstract":"<div>\u0000 \u0000 <p>Managing moderate-to-severe psoriasis in patients with current or past malignancy remains a therapeutic challenge. We conducted a multicentre, retrospective real-world study to assess the safety and effectiveness of guselkumab in this complex population. Thirty patients were included, of whom 11 had active cancer at the time of guselkumab initiation. After 52 weeks of follow-up, guselkumab achieved sustained clinical improvement in skin and joint symptoms, with no observed cases of cancer progression or recurrence. Two patients developed new malignancies during treatment, but guselkumab was not discontinued. These findings support the use of IL-23 inhibitors as a safe therapeutic option in this complex patient population.</p>\u0000 </div>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 6","pages":"359-363"},"PeriodicalIF":1.8,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145012964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intravascular Basal Cell Carcinoma During Mohs Surgery","authors":"Marjia Johns,&nbsp;Nicholas Stewart,&nbsp;Saleem Loghdey,&nbsp;Gilberto Moreno Bonilla","doi":"10.1111/ajd.14562","DOIUrl":"https://doi.org/10.1111/ajd.14562","url":null,"abstract":"<div>\u0000 \u0000 <p>Intravascular invasion of basal cell carcinoma is an exceedingly rare finding during Mohs' micrographic surgery. We present three cases and discuss its significance and management implications.</p>\u0000 </div>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 6","pages":"e361-e364"},"PeriodicalIF":1.8,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145012181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Zosteriform Primary Cutaneous Marginal Zone Lymphoma—A Case Report","authors":"Natalie Teh,&nbsp;Lachlan Byth,&nbsp;Victor Loh,&nbsp;Mrudula Krishnaswamy,&nbsp;Samuel Zagarella","doi":"10.1111/ajd.14565","DOIUrl":"https://doi.org/10.1111/ajd.14565","url":null,"abstract":"<p>We report a case of zosteriform PCMZL presenting in a T3–T4 dermatomal distribution not previously described in the literature. Although the varicella zoster virus was not detected in this case, late diagnosis of the acute eruption of zoster or even preceding zoster ‘sine herpete’ cannot be excluded as antigenic triggers.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 6","pages":"e365-e368"},"PeriodicalIF":1.8,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajd.14565","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145012182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"How Dermatologically Aligned Are Territory Doctors? Assessing Dermatology Referrals in Darwin for Diagnostic and Therapeutic Concordance","authors":"Nicholas Hayes,&nbsp;Christopher Ross,&nbsp;Crystal Williams,&nbsp;Dev Tilakaratne","doi":"10.1111/ajd.14561","DOIUrl":"10.1111/ajd.14561","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background/Objectives</h3>\u0000 \u0000 <p>A significant number of dermatological presentations in Australia are managed by general practitioners and non-dermatologist health professionals. This audit examines the agreement between referring physicians and dermatologists in a tropical regional setting to identify opportunities for collaborative education and support.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A retrospective audit was conducted at a privately billing dermatology practice in Darwin, Northern Territory of the referrals for 479 patients from January to March 2022. Particular attention was given to the concordance in diagnoses and treatments initiated. A subset of 131 referrals focused on skin cancer surveillance.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Only a third of skin cancer referrals included a provisional diagnosis, but, where provided, this corresponded with the dermatologists' assessments 62% of the time. There was 100% diagnostic concordance for presentations of melasma, molluscum/verruca and hidradenitis suppurativa. For acne, hyperhidrosis, and vitiligo, concordance rates ranged from 72.7%–93%. However, treatment concordance was low across all non-skin cancer conditions, with no treatment prescribed by the referring practitioner for more than one quarter of all patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This audit identified deficiencies in the diagnosis of skin cancer and the management of other dermatological conditions, indicating opportunities for interprofessional collaboration with targeted education to enhance the management and treatment outcomes of dermatological conditions in the Northern Territory.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 6","pages":"e355-e360"},"PeriodicalIF":1.8,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144567014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnosis of Allergic Contact Dermatitis With the New Zealand Baseline Series.","authors":"Aysha Wilson, Harriet Kennedy","doi":"10.1111/ajd.14555","DOIUrl":"https://doi.org/10.1111/ajd.14555","url":null,"abstract":"<p><strong>Background/objectives: </strong>The New Zealand Baseline Series (NZBS) was developed in 2021 to ensure local patch testing was relevant to the population of New Zealand (NZ). It consists of 30 Core allergens and 30 Extended allergens. The aim of this study was to assess performance of the NZBS in diagnosing allergic contact dermatitis (ACD).</p><p><strong>Methods: </strong>A retrospective review was performed of patients patch tested between February 2022 and December 2023, at a public tertiary dermatology clinic and at a private dermatology clinic in Auckland, NZ. Patient demographics and the positivity rate of each allergen were recorded. Performance of the NZBS in diagnosing ACD was categorised as full detection (all relevant allergens identified), partial detection (some, but not all, relevant allergens identified) and no detection (no relevant allergens identified).</p><p><strong>Results: </strong>In total, 209 patients were included in data analysis; 94 from the public clinic and 115 from the private clinic. In total, 105 patients (50%) were diagnosed with ACD with at least one relevant reaction on patch testing. Of those diagnosed with ACD, testing against the NZBS (60 allergens) had a full detection rate of 66%, partial detection in 21% and no detection in 13%.</p><p><strong>Conclusions: </strong>Patch testing with the NZBS has a good detection rate for diagnosing ACD. However, detection of all relevant allergens requires supplementation with additional series and patients' own products. Regular updates to the series are required to improve diagnostic value in the population. We suggest combining study results, literature review and expert consensus to identify emerging or missed allergens not currently captured by the NZBS.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144537946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}